Connect with us

Hi, what are you looking for?

Stock

European shares end week in the red as earnings disappoint

By Paolo Laudani, Ankika Biswas and Johann M Cherian

(Reuters) -Europe’s main stock index closed Friday’s choppy session flat and notched weekly losses, as a handful of weak corporate earnings from auto-related companies such as Mercedes-Benz (OTC:MBGAF) and Valeo (EPA:VLOF) and appliances-maker Electrolux dented investor sentiment.

The pan-European STOXX 600 closed flat for the second straight day and logged its first weekly loss in three, with real estate stocks (SX86P) among the worst-hit sectors for the week.

Auto stocks also ended the session on a muted note, with Germany’s Mercedes-Benz dropping 1% after third-quarter earnings in core car division missed estimates by a wide margin.

Valeo added to the sector’s woes, tanking 9.5% as the automotive supplier cut its annual sales guidance for the second time this year.

Electrolux slumped 14.6% to the bottom of the main index after missing third-quarter earnings expectations on continuing U.S. losses and rising competition from China.

Of the STOXX 600 companies that have reported third-quarter earnings, 35.3% beat estimates versus the typical beat rate of 54%, LSEG data showed earlier this week.

Equities have struggled of late, with the STOXX 600 losing momentum after hitting record highs multiple times this year, as investors navigate corporate earnings, the global rate-cut trajectory and the upcoming U.S. election.

Aiding some relief on the day, a survey showed German business morale improved more than expected in October, offering hope for some respite towards the year-end. Traders now brace for third-quarter gross domestic product data due next week.

“Even if growth this year turns out to be slightly negative, we believe the current state of the economy would be better described as stagnation than a recession. The big picture is that Germany’s economy has not grown for another year and remains stuck at pre-pandemic levels,” Robin Winkler, chief economist at Deutsche Bank, wrote.

In bright spots, lights-maker Signify jumped 10% and topped the STOXX as a largely in-line quarterly report and expectations of cost-cutting measures provided relief.

Sanofi (NASDAQ:SNY) added 2.5% and topped the French CAC 40 index after the drugmaker posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start to the vaccination season.

Hexagon was up 3.8% after the Swedish industrial technology group said it is mulling a spin-off of its Asset Lifecycle Intelligence business.

British lender NatWest climbed 3.8% after raising its income forecast for 2024.

This post appeared first on investing.com






    You May Also Like

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com